Translating Computational Models into a More Predictable Patient Outcome for Structural Heart Interventions

With every patient’s anatomy being unique, the outcome of structural heart interventions depends heavily on the interaction between the device and that specific patient. As a leader in personalized computational modeling and simulation for trans-catheter structural heart interventions, FEops applies routine preoperative imaging data to predict the device position and deformation.

With their CE-marked TAVI guide, which allows to predict serious complications such as PVL and conduction abnormalities, FEops brings science to procedure planning as opposed to traditional measuring on anatomy. A methodology that will certainly add value to TAVI in treating complex anatomies such as patients with bicuspid aortic valves and TMVR as the mitral valve is much more complex in anatomy and fysiology than the aortic valve.

Today, CEO and co-founder of FEops Dr. Ir. Matthieu De Beule will talk about how computational modelling and simulation can give medical device companies the opportunity to integrate valve design with patient-specific testing, and to do so virtually, cost-effectively and in a clinically meaningful way.

What you will learn

  • How medical device companies can use computational modelling and simulation to integrate valve design with personalized testing
  • How to do so virtually, cost-effectively and in a clinically meaningful way


Share on:

Share on Facebook
Share on Twitter
Share on LinkedIn
Share with Pocket

Materialise medical device software may not be available in all markets because product availability is subject to the regulatory or medical practices in individual markets. In countries where no regulatory registration is obtained of Mimics or 3-matic Medical, a research version is available. Please contact your Materialise representative if you have questions about the availability of Materialise medical device software in your area.


You might also like

More inspiration